Jang, Sekwon

Phase 1 dose escalation study of MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors.

Jang, S., Powderly, J. D., Spira, A. I., Bakkacha, O., Loo, D., Bohac, G. C., & Sharma, M. (2021) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies Research

Cited by 46

Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy

Sadaat, M., & Jang, S. (2018) · Journal of Oncology Practice

Cancer Immunotherapy and BiomarkersRenal Transplantation Outcomes and Treatments

Cited by 23

Depression and quality of life in cancer patients undergoing chemotherapy: relation between the Zung Self-Rating Depression Scale and Functional Assessment of Cancer Therapy-General

Jang, S., Ackler, J., Braitman, L., & Tester, W. (2012) · Community Oncology

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 1